Status:
COMPLETED
Implementation of Evidence-based Psychotherapy for PTSD
Lead Sponsor:
Toronto Metropolitan University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Approximately 9% of Canadians will have Posttraumatic Stress Disorder (PTSD) in their lifetime. In the military veteran population, the lifetime prevalence of PTSD has been estimated to be as high as ...
Eligibility Criteria
Inclusion
- Clinician participants (n=120) recruited for this study will either be Operation Stress Injury (OSI) network clinicians, Operational Trauma and Stress Support Centre (OTSSC) network clinicians or community-based clinicians who treat military-related PTSD.
- Both male and female clinician participants will be recruited;
- Clinician participants will be greater than 18 years.
- Mental health clinicians from the clinics and private practitioners will be eligible to participate in the study if they:
- attend the CPT workshop;
- are employees of an OSI or OTSSC clinic, are registered VAC clinicians, or are in private practice treating individuals with military-related PTSD;
- currently provide psychotherapy to military soldiers or veterans with PTSD;
- consent to be randomized to one of the three study conditions; and,
- are willing to solicit patient participation.
- Eligible patient participants are:
- client of the clinician participant, who has a diagnosis of PTSD, as determined by clinician independent assessment, and total PCL score equal or greater to 45; and
- willing to consent to have their sessions audiorecorded and listened to by a fidelity rater and potentially other clinicians teaching and learning CPT. Patients are permitted to continue other psychotherapeutic interventions if not specifically focused on treating PTSD symptoms. Patient participants must be over the age of 18.
Exclusion
- Ineligible patients will include those not eligible for CPT based on the state of research evidence, including those with:
- current uncontrolled psychotic or bipolar disorder;
- unremitted substance dependence diagnosis (substance abuse allowed);
- current imminent suicidality or homicidality that requires imminent attention; and
- significant cognitive impairment.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01861769
Start Date
February 1 2012
End Date
October 1 2014
Last Update
November 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edmonton Operational Stress Injury Clinic
Edmonton, Alberta, Canada, T5E 5R8